Itau Unibanco Holding S.A. Repligen Corp Transaction History

Itau Unibanco Holding S.A.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$120.0 - $182.95 $3,720 - $5,671	31 New	31 $3,000
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $1,826 - $2,965	-16 Reduced 18.18%	72 $12,000
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $55,789 - $70,957	-402 Reduced 82.04%	88 $13,000
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $22,562 - $29,390	-163 Reduced 24.96%	490 $69,000
Q1 2023 May 12, 2023	BUY	$154.26 - $198.1 $85,305 - $109,549	553 Added 553.0%	653 $109,000
Q4 2022 Feb 09, 2023	BUY	$162.42 - $220.56 $16,241 - $22,056	100 New	100 $16,000
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $15,193 - $20,306	108 New	108 $18,000
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $47,537 - $58,458	-192 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $973 - $1,621	5 Added 2.67%	192 $55,000
Q2 2021 Aug 17, 2021	BUY	$165.87 - $220.95 $31,017 - $41,317	187 New	187 $37,000

486

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.71B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.